trastuzumab,neratinib
roche,puma
['neratinib', 'summit', 'puma', '$pbyi']
$pbyi [15s. delayed]: issued press release on september 11, 05:15:00: puma biotechnology presents updated findings from the phase ii summit basket trial of neratinib for her2-mutant, recurrent/metastatic cervical cancer at the esmo congress 2022 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time